Radiofrequency ablation - Is a technique finished?;Radiofrequenzablation - Ist eine technik am ende?

Radiologe

Volumn 52, Issue 1, 2012, Pages 9-14

  Wiggermann, P ^a   Jung, E M ^a   Stroszczynski, C ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Computed tomography (CT); Contrast enhanced ultrasound (CEUS); Hepatocellular carcinoma (HCC); Liver metastases; Radiofrequency ablation (RFA)

Indexed keywords

ARTICLE; CATHETER ABLATION; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIVER RESECTION; LIVER TUMOR; RADIOGRAPHY;

CATHETER ABLATION; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857175179     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-011-2206-y     Document Type: Article

References (33)

1. Ayav A, Germain A, Marchal F et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435-439
2. Bartolotta TV, Taibbi A, Midiri M et al (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34:193-209
3. Becker HC, Meissner O, Waggershauser T (2009) C-arm CT-guided 3D navigation of percutaneous interventions. Radiologe 49:852-855
4. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236 (Pubitemid 43112690)
5. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430 (Pubitemid 32844200)
6. Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-328 (Pubitemid 43327762)
7. Diehn FE, Neeman Z, Hvizda JL et al (2003) Remote thermometry to avoid complications in radiofrequency ablation. J Vasc Interv Radiol 14:1569-1576 (Pubitemid 37517635)
8. Eckey T, Neumann A, Bohlmann MK et al (2011) Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound. Radiologe 51:610-619
9. Farrell MA, Charboneau JW, Callstrom MR et al (2003) Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol 181:1315-1317 (Pubitemid 37296409)
10. Forner A, Reig ME, De Lope CR et al (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30:61-74
11. Frieser M, Kiesel J, Lindner A et al (2011) Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies. Ultraschall Med 32:148-153
12. Gillams AR, Lees WR (2008) Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 19:712-717
13. Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206-1213
14. Goldberg SN, Gazelle GS, Compton CC et al (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452-2463 (Pubitemid 30331950)
15. Helmberger T, Dogan S, Straub G et al (2007) Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 75:104-112 (Pubitemid 47343961)
16. Jung EM, Schreyer AG, Schacherer D et al (2009) New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. Clin Hemorheol Microcirc 43:57-69
17. Jung EM, Uller W, Stroszczynski C et al (2011) Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma. Radiologe 51:462-468
18. Kamusella P, Wiggermann P, Wissgott C et al (2011) Thermal protection of targeted air instillation in ct-guided radiofrequency ablation. Rofo, in press
19. Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235-240 (Pubitemid 36736097)
20. Lin SM, Lin CJ, Lin CC et al (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151-1156
21. Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441-451 (Pubitemid 36313433)
22. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-338
23. Mazzaferro V, Battiston C, Perrone S et al (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240:900-909 (Pubitemid 39425785)
24. Meloni MF, Livraghi T, Filice C et al (2006) Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents. Ultrasound Q 22:41-47 (Pubitemid 44510226)
25. Morimoto M, Numata K, Kondou M et al (2010) Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 116:5452-5460
26. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158-171 (Pubitemid 41033431)
27. Porrett PM, Peterman H, Rosen M et al (2006) Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 12:665-673
28. Ross CJ, Rennert J, Schacherer D et al (2010) Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): preliminary results. Clin Hemorheol Microcirc 46:101-115
29. Ruers T, Punt C, Van Coevorden F et al (2010) Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). J Clin Oncol 28:3526
30. Schraml C, Schwenzer NF, Clasen S et al (2009) Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 29:1308-1316
31. Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122-130 (Pubitemid 41002049)
32. Wang W, Shi J, Xie WF (2010) Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 30:741-749
33. Yamakado K, Nakatsuka A, Akeboshi M et al (2003) Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 14:1183-1186 (Pubitemid 37193733)